S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

CRH Medical Stock Price, Forecast & Analysis (NYSEAMERICAN:CRHM)

$3.07
-0.15 (-4.66 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$3.06
Now: $3.07
$3.20
50-Day Range N/A
52-Week Range
$2.51
Now: $3.07
$3.79
Volume81,600 shs
Average Volume55,922 shs
Market Capitalization$220.09 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:CRHM
Previous SymbolNYSEARCA:CRHM
CUSIPN/A
CIKN/A
Phone+1-604-6331440

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees112
Market Cap$220.09 million
Next Earnings Date3/11/2020 (Estimated)
OptionableNot Optionable

Receive CRHM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRHM and its competitors with MarketBeat's FREE daily newsletter.


CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions

What is CRH Medical's stock symbol?

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

How were CRH Medical's earnings last quarter?

CRH Medical Corp (NYSEAMERICAN:CRHM) posted its earnings results on Thursday, November, 7th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.02. The business had revenue of $30.42 million for the quarter, compared to analyst estimates of $31.50 million. View CRH Medical's Earnings History.

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for CRH Medical.

What is the consensus analysts' recommendation for CRH Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CRH Medical.

Has CRH Medical been receiving favorable news coverage?

Headlines about CRHM stock have trended very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CRH Medical earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for CRH Medical.

Are investors shorting CRH Medical?

CRH Medical saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 42,300 shares, a decline of 14.5% from the September 30th total of 49,500 shares. Based on an average daily volume of 32,200 shares, the days-to-cover ratio is presently 1.3 days. Currently, 0.1% of the shares of the stock are sold short. View CRH Medical's Current Options Chain.

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:
  • Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
  • Mr. James Kreger, Pres of CRH Anesthesia Management
  • Ms. Kettina Cordero, Director of Investor Relations

Who are CRH Medical's major shareholders?

CRH Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Beutel Goodman & Co Ltd. (6.29%) and CLARET ASSET MANAGEMENT Corp (0.23%). View Institutional Ownership Trends for CRH Medical.

Which institutional investors are selling CRH Medical stock?

CRHM stock was sold by a variety of institutional investors in the last quarter, including Beutel Goodman & Co Ltd.. View Insider Buying and Selling for CRH Medical.

Which institutional investors are buying CRH Medical stock?

CRHM stock was acquired by a variety of institutional investors in the last quarter, including CLARET ASSET MANAGEMENT Corp. View Insider Buying and Selling for CRH Medical.

How do I buy shares of CRH Medical?

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRHM stock can currently be purchased for approximately $3.07.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $220.09 million. CRH Medical employs 112 workers across the globe.View Additional Information About CRH Medical.

What is CRH Medical's official website?

The official website for CRH Medical is http://investors.crhsystem.com/.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  172 (Vote Underperform)
Total Votes:  351
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRHM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel